Lewis Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
- Paid Up Capital ₹ 1.50 M
- Company Age 5 Year, 11 Days
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.50 Cr
- Revenue Growth 44.73%
- Profit Growth 168.03%
- Ebitda -21.78%
- Net Worth 72.07%
- Total Assets 5.49%
About Lewis Pharmaceuticals
Lewis Pharmaceuticals Private Limited (LPPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 January 2020 (Five years 11 days old ). Its registered office is in Surat, Gujarat, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 1.50 M.
The company currently has active open charges totaling ₹1.50 Cr.
Umang Patel and Jignesh Solanki serve as directors at the Company.
Company Details
-
Location
Surat, Gujarat, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24290GJ2020PTC112260
-
Company No.
112260
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 Jan 2020
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Ahmedabad
Industry
Who are the key members and board of directors at Lewis Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Umang Patel
|
Director | 23-Jan-2020 | Current |
|
Jignesh Solanki
|
Director | 23-Jan-2020 | Current |
Financial Performance of Lewis Pharmaceuticals.
Lewis Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 44.73% increase. The company also saw a substantial improvement in profitability, with a 168.03% increase in profit. The company's net worth Soared by an impressive increase of 72.07%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Lewis Pharmaceuticals?
Unlock access to Lewis Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
-
Lewis Renewable Energy Park Private LimitedJignesh Solanki is a mutual person
-
Lewis Energy Solutions Private Limited
Jignesh Solanki is a mutual person
-
Lewis Enterprises Private Limited
Jignesh Solanki is a mutual person
-
Lewis Green Energy Private Limited
Jignesh Solanki is a mutual person
-
Lewis Solar Private Limited
Jignesh Solanki is a mutual person
Charges (Loans)
₹15.00 M
₹0
Charges Breakdown by Lending Institutions
- Axis Bank Limited : 1.50 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jan 2024 | Axis Bank Limited | ₹1.50 Cr | Open |
How Many Employees Work at Lewis Pharmaceuticals?
Unlock and access historical data on people associated with Lewis Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Lewis Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Lewis Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.